Predicting pathological response of esophageal cancer to neoadjuvant chemotherapy: the implications of metabolic nodal response for personalised therapy
INTRODUCTION<br/> Only a minority of esophageal cancers demonstrates a pathological tumor response (pTR) to neoadjuvant chemotherapy (NAC). 18F-fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) is often used for restaging after NAC and to assess response. Incre...
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Publié: |
Society of Nuclear Medicine
2016
|